Abstract
Due to the great interest of androgen signaling in castration-resistant prostate cancer, there is an urgency to identify new molecules that may in the future serve both as biomarkers and for therapeutic purposes in prostate cancer. In this sense, the cofactors of the androgen receptor emerge as attractive molecules, since the androgen receptor manages to recruit key enzymatic cofactors fo…